RxDoctor Payments Data

Ufuk Vardar, MD

Cardiovascular Disease · Jacksonville, FLNPI 1922625268

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,535 of the $2,173 with a category attached, or 70.6%. 15 manufacturers reported payments, led by Abbott at 24.2% of the total. 2025 is the largest year on record at $1,587, more than ten times the $103 reported in 2022. That places this record below the midpoint for cardiovascular disease clinicians in FL, where the typical reported total is $2,774.

$2,173in general payments, 2019–2025

Across 21 payments — averaging $103.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$527
  • Novartis$318
  • Biosense Webster, Inc.$261
  • Boston Scientific$133
  • Amgen$125
  • Shockwave Medical, Inc$124
  • plus $684 from 9 others

What the payments were for

  • Food & beverage$1,53571%
  • Education$63829%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,173 in reported general payments places this provider in the 40th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024
$6,590
Medicare patients
45
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium14$273

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →